Semi-Annual Consolidated Statement Of Cash Flows

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7586092

Concept As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
3,019,000,000 JPY
-4,139,000,000 JPY
Depreciation
1,527,000,000 JPY
1,346,000,000 JPY
Impairment losses
JPY
5,921,000,000 JPY
Interest and dividend income
-185,000,000 JPY
-137,000,000 JPY
Interest expenses
25,000,000 JPY
29,000,000 JPY
Increase (decrease) in retirement benefit liability
132,000,000 JPY
221,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
21,000,000 JPY
-51,000,000 JPY
Decrease (increase) in trade receivables
-1,876,000,000 JPY
-1,697,000,000 JPY
Decrease (increase) in inventories
-1,096,000,000 JPY
730,000,000 JPY
Increase (decrease) in trade payables
-27,000,000 JPY
-254,000,000 JPY
Other, net
397,000,000 JPY
234,000,000 JPY
Subtotal
1,907,000,000 JPY
2,203,000,000 JPY
Interest and dividends received
184,000,000 JPY
137,000,000 JPY
Interest paid
-26,000,000 JPY
-30,000,000 JPY
Income taxes paid
-398,000,000 JPY
-894,000,000 JPY
Net cash provided by (used in) operating activities
1,666,000,000 JPY
1,417,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-292,000,000 JPY
-262,000,000 JPY
Proceeds from sale of investment securities
56,000,000 JPY
JPY
Other, net
58,000,000 JPY
22,000,000 JPY
Net cash provided by (used in) investing activities
-199,000,000 JPY
-427,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-1,149,000,000 JPY
-1,149,000,000 JPY
Dividends paid
-225,000,000 JPY
-199,000,000 JPY
Net cash provided by (used in) financing activities
-1,346,000,000 JPY
-1,386,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
0 JPY
0 JPY
Net increase (decrease) in cash and cash equivalents
121,000,000 JPY
-396,000,000 JPY
Cash and cash equivalents
17,224,000,000 JPY
17,103,000,000 JPY
10,117,000,000 JPY
10,514,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.